We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZTS:NYSEZoetis Inc. analysis

Data as of Oct 12, 2026 - not real-time

Latest price
$74.81
Risk: medium
5/10Medium risk

Summary

Zoetis Inc. is priced at $74.81 and its moving averages line up in bearish order, the shorter trailing the longer. Momentum indicators put RSI at 59.5 (neutral) with MACD reading bullish. Price has been bracketed by support at $68.77 and resistance at $74.85.
Valuation screens as undervalued: a P/E of 12.3 sits below the sector average of 30.5. The average analyst target implies 28.3% above today's level. The 2.90% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 23.1%, a beta of 0.56 and a maximum drawdown of 53.2%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top market events

  • Zoetis Inc. NYSE:ZTS entered 2026 as a leader in animal health, but its latest earnings show that even a strong market...
  • Despite a challenging US market and increased competition, Zoetis leverages its diversified portfolio and disciplined...
  • Revenue hit USD 2.47 billion in second quarter, down 0.20 percent year over year. USD 101.08 target

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 97.09
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 12.3 versus sector average of 30.5
  • Trading below the 200-day average of 97.09

Long term

> 3 years

Positive

Model confidence4/104 out of 10

Key factors

  • P/E of 12.3 versus sector average of 30.5
  • Analyst targets imply +28.3% versus the current price
  • Profit margin of 27.7% is healthy

Key metrics

Financial health

Revenue Growth-0.20%
Profit Margin27.68%
P/E Ratio12.3
ROE64.91%
ROA15.35%
Debt/Equity294.00
P/B Ratio9.5
Op. Cash Flow$2.8B
Free Cash Flow$2.0B
Industry P/E30.5

Technical analysis

TrendBearish
RSI59.5
Support$68.77
Resistance$74.85
MA 20$71.71
MA 50$73.97
MA 200$97.09
MACDBullish
VolumeStable
Fear & Greed Index93.8

Valuation

Fair Value$39.90
Target Price$96.00
Upside/Downside28.33%
GradeUndervalued
TypeBlend
Dividend Yield2.90%

Risk assessment

Beta0.56
Volatility23.06%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.